Roche's (RHHBY) cobas SARS-CoV-2 Qualitative test has received CE mark for the use of saliva samples in the detection of SARS-CoV-2 on cobas 6800/8800 Systems, the company said in a statement.
The non-invasive test is for any individual, including those suspected of COVID-19 and those without symptoms.
Saliva sample collection is an easy, non-invasive and convenient testing experience for patients who can self-collect their saliva sample.
Roche noted that it continues to develop testing options that deliver accurate detection and correctly identify SARS-CoV-2 mutations to help patients and healthcare providers manage the evolving COVID-19 pandemic.
For comments and feedback: editorial@rttnews.com